[Close]
- This page was created by volunteers like you!
- Help us make it even better. To learn more about contributing to MEpedia, click here.
- Join the movement
- Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
- Congratulations!
- MEpedia has got over 30 million views as of August 2022!
Sodium oxybate
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
 | This article is a stub. |
Sodium oxybate or gamma-hydroxybutyrate (GHB) is sold under the brand name Xyrem is a restricted prescription drug licensed for the prevention of cataplexy (sudden, brief episodes of loss of muscle strength) and narcolepsy.[1][2]
Prescription sodium oxybate and Xyrem have significant differences from the illegal street drug also known as GHB.[3]
Side effects[edit | edit source]
Learn more[edit | edit source]
- Sodium oxybate - drugs.com
- Sodium oxybate - MedlinePlus
See also[edit | edit source]
References[edit | edit source]
- ↑ "Sodium oxybate Uses, Side Effects & Warnings". Drugs.com. Retrieved September 25, 2020.
- ↑ "Sodium Oxybate: MedlinePlus Drug Information". medlineplus.gov. Retrieved September 25, 2020.
- ↑ Carter, Lawrence P.; Pardi, Daniel; Gorsline, Jane; Griffiths, Roland R. (September 1, 2009). "Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): differences in characteristics and misuse". Drug and alcohol dependence. 104 (1–2): 1–10. doi:10.1016/j.drugalcdep.2009.04.012. ISSN 0376-8716. PMC 2713368. PMID 19493637.
